bit.bio raises $30 million led by M&G Investments

bit.bio, the global leader in cell programming technology, today announced the successful closing of a $30 million financing round led by M&G Investments, a leading international savings and investment company.

KeyMed partners with US-based biotech Prolium in bispecific antibody deal – Pharmaceutical Technology

Prolium will make a $17.5m upfront payment, with potential milestone payments totalling $502.5m. Credit: uniquepixel via Getty Images. Investment company RTW Investments has launched a

January 20, 2025

Are AI chatbots more creative than humans? New study reveals surprising results

The study published in Scientific Reports compared human and AI chatbot creativity using the alternate uses task (AUT), finding that AI chatbots generally outperformed humans

September 18, 2023

Sweeping bill to fight opioid addiction will be considered by Senate health committee

The Senate health care committee will consider a sweeping bill next week meant to combat the opioid epidemic, according to four lobbyists and a congressional

December 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.